Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium-derived factor in brown Norway and Sprague dawley rats contributing to different susceptibilities to retinal neovascularization

Diabetes

Volumn 51, Issue 4, 2002, Pages 1218-1225

  Gao, Guoquan ^a   Li, Yan ^a   Fant, James ^a   Crosson, Craig E ^a   Patricia Becerra, S ^b   Jian xing, Ma ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HYPEROXIA; METABOLIC REGULATION; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RAT; RAT STRAIN; RETINA ANGIOGRAPHY; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; STRAIN DIFFERENCE;

EID: 0036228537     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.4.1218     Document Type: Article

References (32)

1. Diabetic retinopathy
2. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy
3. Childhood blindness
4. Epidemiology of proliferative diabetic retinopathy
5. Treatment of diabetic retinopathy
6. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
7. Structure-function studies on PEDF: A noninhibitory serpin with neurotrophic activity
8. Identification of pigment epithelium-derived factor in the interphotoreceptor matrix of bovine eyes
9. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
10. Animal models of diabetic retinopathy
11. Vitamin E in kitten oxygen-induced retinopathy. II. Blockage of vitreal neovascularization
12. Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture
13. Oxygen-induced retinopathy in the mouse
14. Postnatal retinal vascular development of the puppy
15. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat
16. Oxygen-induced retinopathy in the rat model
17. Oxygen-induced proliferative retinopathy in the newborn rat
18. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat
19. Variable oxygen exposure causes preretinal neovascularization in the newborn rat
20. Oxygen-induced retinopathy in the rat: Relationship of retinal nonperfusion to subsequent neovascularization
21. The effect of litter size on normal retinal vascular development in the neonatal rat
22. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats
23. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization
24. Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy
25. Molecular mechanisms of blood vessel formation
26. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases
27. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
28. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
29. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
30. Genetic heterogeneity of angiogenesis in mice
31. Strain specific phenotypic variation in VEGF-induced choroidal neovascularization in the rat
32. Effect of light on oxygen-induced retinopathy in the rat model: Light and OIR in the rat